1. Introduction & Mechanism of Action of Beqalzi Beqalzi is a potent targeted oncological therapy that functions as a highly selective BCL2 inhibitor indicated for the continuous treatment of specific hematological malignancies. The most notable side effect is the extreme risk of developing tumor lysis syndrome where the rapid destruction of cancer cells violently overwhelms … Read more
1. Introduction & Mechanism of Action of Vegzelma Vegzelma is a targeted biological therapy containing bevacizumab, a recombinant humanized monoclonal antibody utilized extensively in oncology to starve malignant tumors of their blood supply. The most notable side effect involves a profound risk of severe hemorrhagic events and acute hypertension. Bevacizumab acts as a direct angiogenesis … Read more
1. Introduction & Mechanism of Action of Tazverik Tazverik utilizes tazemetostat hydrobromide as a highly specific targeted epigenetic inhibitor for the treatment of epithelioid sarcoma and relapsed or refractory follicular lymphoma. The most notable side effect involves a heightened risk of developing secondary hematological malignancies alongside substantial systemic fatigue. The active ingredient functions by selectively … Read more
1. Introduction And Mechanism Of Action Of Tibsovo Tibsovo is a highly advanced, targeted oral antineoplastic medication containing ivosidenib, explicitly engineered to treat acute myeloid leukemia and specific forms of cholangiocarcinoma. The most notable side effect is a critical, potentially fatal condition known as differentiation syndrome, which triggers massive respiratory distress and fever as the … Read more